Title : Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.

Pub. Date : 2020 Dec

PMID : 33626003






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: BBR could significantly alleviate the liver tissue steatosis and inflammatory cell infiltration; reduce the NAFLD activity scores and serum levels of ALT, AST, TC, and LDL-C; decrease the levels of TNF-alpha, IL-6, and IL-1beta, and reduce the expression of TLR4, MyD88, and NF-kappaB in the liver tissues. Berberine tumor necrosis factor Rattus norvegicus